Stephen Johnson

Array ( [id] => 5404561 [patent_doc_number] => 20090239875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Protection of ferulic acid and/or tetramethylpyrazine against retinal ischaemia, glaucoma and siderosis oculi' [patent_app_type] => utility [patent_app_number] => 12/053425 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12521 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239875.pdf [firstpage_image] =>[orig_patent_app_number] => 12053425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057474 [patent_doc_number] => 09096819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer' [patent_app_type] => utility [patent_app_number] => 12/023509 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9233 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12023509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575553 [patent_doc_number] => 20100047177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES' [patent_app_type] => utility [patent_app_number] => 12/524718 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17625 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047177.pdf [firstpage_image] =>[orig_patent_app_number] => 12524718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956015 [patent_doc_number] => 08501789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Use of salicylaldehyde isonicotinoyl hydrazone (SIH) for protection against retinal disease' [patent_app_type] => utility [patent_app_number] => 12/010090 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 9620 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12010090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342336 [patent_doc_number] => 20090180986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'TREATING UNWANTED OCULAR CONDITIONS USING AN ASCOMYCIN MACROLACTAM' [patent_app_type] => utility [patent_app_number] => 12/014938 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3974 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20090180986.pdf [firstpage_image] =>[orig_patent_app_number] => 12014938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710680 [patent_doc_number] => 20080299206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Ophthalmic preparations' [patent_app_type] => utility [patent_app_number] => 12/007902 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11251 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299206.pdf [firstpage_image] =>[orig_patent_app_number] => 12007902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4766035 [patent_doc_number] => 20080177247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'CONTROLLED PUPIL DILATION FOR DIAGNOSTIC AND TREATMENT OF VISUAL ANOMALIES' [patent_app_type] => utility [patent_app_number] => 11/971851 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4213 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177247.pdf [firstpage_image] =>[orig_patent_app_number] => 11971851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4893019 [patent_doc_number] => 20080102117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'BASE MATERIAL FOR DRY DIRECT TABLETING COMPRISING LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE' [patent_app_type] => utility [patent_app_number] => 11/958462 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3663 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102117.pdf [firstpage_image] =>[orig_patent_app_number] => 11958462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603917 [patent_doc_number] => 20100063035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'CARBONIC ANHYDRASE INHIBITORS DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/516460 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10721 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063035.pdf [firstpage_image] =>[orig_patent_app_number] => 12516460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307653 [patent_doc_number] => 20100069482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS' [patent_app_type] => utility [patent_app_number] => 12/517445 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4732 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069482.pdf [firstpage_image] =>[orig_patent_app_number] => 12517445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550696 [patent_doc_number] => 08063029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 11/930812 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12754 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063029.pdf [firstpage_image] =>[orig_patent_app_number] => 11930812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177260 [patent_doc_number] => 08178518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 11/931809 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12665 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178518.pdf [firstpage_image] =>[orig_patent_app_number] => 11931809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771342 [patent_doc_number] => 20080057000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'DENTAL COMPOSITIONS HAVING ANTI-STOKES UP CONVERTERS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/931290 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7657 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057000.pdf [firstpage_image] =>[orig_patent_app_number] => 11931290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894021 [patent_doc_number] => 20080103120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 11/929610 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12672 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103120.pdf [firstpage_image] =>[orig_patent_app_number] => 11929610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960587 [patent_doc_number] => 20080275012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 11/928467 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12747 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275012.pdf [firstpage_image] =>[orig_patent_app_number] => 11928467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880526 [patent_doc_number] => 20080153909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/873478 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9470 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153909.pdf [firstpage_image] =>[orig_patent_app_number] => 11873478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280893 [patent_doc_number] => 20100119609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHODS, COMPOSITIONS, AND FORMULATIONS FOR THE TREATMENT OF THYROID EYE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/445570 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14938 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119609.pdf [firstpage_image] =>[orig_patent_app_number] => 12445570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627908 [patent_doc_number] => 20100172981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Ibuprofen-Effervescent Preparation Having a High Dissolution Rate and Method for the Production thereof' [patent_app_type] => utility [patent_app_number] => 12/443107 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8464 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172981.pdf [firstpage_image] =>[orig_patent_app_number] => 12443107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833946 [patent_doc_number] => 20080132493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS FOR NEEDLELESS INJECTION' [patent_app_type] => utility [patent_app_number] => 11/845675 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2490 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132493.pdf [firstpage_image] =>[orig_patent_app_number] => 11845675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652195 [patent_doc_number] => 20080039451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria' [patent_app_type] => utility [patent_app_number] => 11/894004 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4003 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039451.pdf [firstpage_image] =>[orig_patent_app_number] => 11894004 [rel_patent_id] =>[rel_patent_doc_number] =>)